Objectives: to study the prevalence of lactose malabsorption with increasing age and to determine whether lactose malabsorbers consume less dietary calcium, have lower bone mineral density or display faster bone loss than lactose absorbers. Design: 80 healthy Caucasian women aged 40-79 years (20 per decade) were studied for 1 year. Methods: breath hydrogen exhalation was measured for 3 h after a 50 g oral lactose challenge. Bone density was assessed in the radius, femoral neck, lumbar spine and total body by dual energy x-ray absorptiometry and dietary calcium intake was estimated by 4-day diet records and food-frequency questionnaires. Results: lactose malabsorption rose with age (15% in those aged 40-59 years versus 50% in those aged 60-79; P < 0.01). Malabsorbers aged 70-79 years consumed significantly less calcium than lactose absorbers of this age (P < 0.05). Baseline total body calcium values were lower in lactose malabsorbers (n = 26) than in lactose absorbers (n = 54) but age-adjustment eliminated this difference. Bone change (% per year) was correlated with dietary calcium intake at the femoral neck and trochanter (P < 0.05) but was not statistically greater in malabsorbers than in absorbers. Conclusions: the ability to absorb lactose declines in the 7th decade. This may contribute to decreased dietary intakes of milk products and calcium in elderly women. However, lactose malabsorption without reduction in calcium intake has little effect on bone mineral density or the rate of bone loss.
Introduction
Impaired ability to absorb lactose, the main sugar in milk, has long been considered a risk factor for osteoporosis [1] . The view that lactose malabsorption is associated with a reduced bone density is supported by four lines of evidence. First, an adequate intake of calcium is needed to build and to conserve good bone mass [2] [3] [4] [5] [6] , and dietary calcium intake (especially from milk) is often considerably lower in lactose malabsorbers than in lactose absorbers [7, 8] . Secondly, some groups have reported a higher prevalence of lactose malabsorption in osteoporotic than in non-osteoporotic populations [9, 10] . Thirdly, lactose may enhance alimentary calcium absorption in lactose absorbers but reduce this in malabsorbers [11] . Lastly, lower bone density values at the hip and spine have been observed in symptomatic lactose absorbers, the osteopenia being ascribed to reduced dietary calcium consumption as a consequence of milk avoidance [8, 12, 13] .
On the other hand, many lactose malabsorbers maintain good calcium intakes [14] , osteoporotic and non-osteoporotic groups may show similar prevalence of lactose malabsorption [15] , the alimentary absorption of calcium is not always diminished in malabsorbers [10, 16] , and bone density values in lactose absorbers and malabsorbers may be similar [10, 14, 17, 18] . Thus there no consensus as to whether lactose malabsorption affects bone density adversely.
We recently observed [15] that lactose malabsorption was significantly higher in older women than in young adults (60% prevalence versus l2%). The present prospective study was undertaken to determine in what decade age group the prevalence of lactose malabsorption increased in older New Zealand women. Our study objectives were to evaluate the effects of advancing age on lactose malabsorption and to determine whether lactose malabsorbers consume less dietary calcium, have lower bone mineral density (BMD) or display faster bone loss than lactose absorbers.
Methods
Eighty healthy women volunteers aged 40-79 years (20 per decade) recruited from the community by advertisement, who were not taking any therapy affecting bone, were enrolled in a 12-month study. We were unaware of their customary milk consumption or calcium intakes and no subject had previously been tested for lactose intolerance. We were careful to exclude subjects who had undergone gastrointestinal surgery, radiotherapy, a hip replacement or were known to have malabsorption syndromes, hyperthyroidism, hyperparathyroidism, Cushing's syndrome or any known history of bone or stone disease. We also checked that no antibiotics had been taken within 4 weeks before lactose tolerance testing.
The protocol was approved by our hospital ethics committee. At the first hospital visit, we tested lactose absorption, obtained a medical history, estimated dietary calcium using a food-frequency questionnaire [15] , measured biochemical markers of bone formation (osteocalcin) and bone resorption (hydroxyproline and deoxypyridinoline), determined height and weight, and measured BMD. Subjects were asked to continue their customary diets and 12 months later the same food-frequency questionnaire was administered, 4-day diet records obtained and bone density re-measured.
Lactose absorption was assessed by measuring endalveolar breath hydrogen exhalation at l5 min intervals for 3 h following an oral challenge of 50 g lactose in 200 ml water after overnight fasting, by methods described previously [15] . Subjects with a rise of >10 ppm H 2 above baseline 60-180 min after consuming the lactose load were diagnosed as malabsorbers. Serum osteocalcin concentration was measured with a radioimmunoradiometric assay (Nichols Institute, CA, USA). Urinary hydroxyproline was determined colorimetrically [19] and urinary deoxypyridinoline was estimated with a Pyrilinks-D EIA kit (Metra Biosystems Inc., CA, USA). Bone density was measured by dual x-ray absorptiometry (Lunar DPX-L) at the radius, hip, spine and total body [20] . The precision for BMD measurements in our laboratory (coefficients of variation) is: 1.61% for ultradistal radius, 1.52% for 33% radius, 1.42% for neck of femur, 0.67% for L2-4 and 0.7% for total body.
Statistical analysis
Results are displayed as means and standard errors for the four 10-year age groups and for lactose absorbers and malabsorbers. Simple Pearson correlations illustrate the associations between age and total body calcium and between percentage change in BMD and dietary calcium. We used multiple regression to investigate the effect of adjusting for age, body weight, menopausal status and calcium intakes on the differences between absorbers and malabsorbers at baseline, and the effect of adjusting for differences at baseline, age and body weight on the differences between absorbers and malabsorbers at the end of the study.
The results of eight subjects were omitted from our statistical modelling of annual bone change because during the study two women commenced corticosteroid therapy, five started hormone replacement therapy and one developed malignancy. Only one of the women excluded was a lactose malabsorber.
Results
Breath hydrogen determinations revealed that 26 women were lactose malabsorbers, while 54 were lactose absorbers ( Figure 1 ). Twenty-six women were pre-menopausal (five malabsorbers, 2l absorbers) and 54 were post-menopausal. The prevalence of malabsorption rose sharply and significantly in the 7th decade and remained high and similar in the 7th and 8th decades (Table 1) .
Malabsorbers aged 70-79 years had lower calcium intakes than absorbers, but calcium intakes did not differ in other age groups and values were high overall. Malabsorbers over 70 also obtained less of their total dietary calcium from milk than absorbers (45% versus 58%, P < 0.05). Reported frequency of milk consumption was lower in adulthood than in childhood and this did not differ between malabsorbers and absorbers. Among malabsorbers, 15% reported previous symptoms of gastrointestinal discomfort associated with milk drinking, versus 11% of the absorbers (not significant). Calcium intakes remained stable during the study. Mean intakes estimated by the food-frequency questionnaire at baseline and 1 year were not statistically different. There was also good agreement between final dietary calcium estimations by food-frequency questionnaire and 4-day diet records (r = 0.714).
Malabsorbers were older and shorter than absorbers, with a significantly lower total body content of both calcium and bone mineral (Figure 2 ). However, their unadjusted baseline bone densities did not differ at any site. Age-adjustment alone eliminated the differences between lactose absorbers and malabsorbers in total body calcium and bone mineral, showing that raw data values differed solely because malabsorbers were older than absorbers. After adjusting for age, body weight, menopausal status and dietary calcium, no significant effects of lactose malabsorption were found for any bone variable (Table 2 ). In our study population 35% of malabsorbers and 37% of absorbers had osteopaenia by World Health Organisation criteria (below ¹l SD of young normal BMD values) while 35% of malabsorbers and 30% of absorbers had overt osteoporosis (below ¹2.5 SD of young normal BMD values) [21] .
Analyses of biochemical markers of bone formation and resorption gave similar results in the two groups: the mean levels of serum osteocalcin, urinary hydroxyproline/creatinine and deoxypyridinoline/creatinine in absorbers were 6.38 Ϯ 0.42 ng/ml, 0.017 Ϯ 0.001 mmol/ mmol and 4.05 Ϯ 0.27 nmol/mmol, while the mean levels in malabsorbers were 6.22 Ϯ 0.39 ng/ml, 0.017 Ϯ 0.001 mmol/mmol and 4.85 Ϯ 0.38 nmol/mmol.
During the study, average BMD values fell at every measured site except the lumbar spine ( Figure 3) . We attribute this rise in spinal density to osteoarthritis [22] . In the whole study population, change in BMD (unadjusted data) at the neck of femur (Figure 4 ) and at the hip trochanter (r = 0.254, P < 0.03, data not illustrated) was significantly correlated with dietary calcium intake (4-day record). Change in BMD at other skeletal sites did not show this relationship.
Although malabsorbers tended to show somewhat higher bone loss than absorbers, group differences were not statistically different and, after adjusting for values at the beginning of the study, calcium intake, age and body weight, the effects of lactose malabsorption on bone variables 1 year later are small and nonsignificant (Table 3 ). This was also true if no adjustments were made for calcium intake. There was a tendency for change at most bone sites to be slightly more negative in malabsorbers than absorbers.
Discussion
We have confirmed that lactose malabsorption increases in frequency with advancing age in Caucasian New Zealand women [15] . Presumably this rising prevalence of malabsorption is due to declining lactase activity in the ageing intestinal mucosa. Our results establish that the main rise in malabsorption occurs in the 7th decade, 55% of subjects aged 60-69 years displaying poor absorption of lactose in comparison with l5% in women under 60. The prevalence of malabsorption we report is similar to that observed previously (12% in 50 women aged l7-30 years of age and 60% in 31 women over 60) [15] . Up to 30% of the population may have non-hydrogen producing colonic flora: breath hydrogen testing will underestimate the prevalence of lactose malabsorption in these subjects [23] . Our study design deliberately excluded individuals with malabsorption or previous intestinal surgery who frequently have lactose malabsorption. Thus, the true prevalence of malabsorption in a representative population sample of elderly New Zealand women could be even higher. A decreased intake of milk, rather than total milk avoidance, generally occurs in lactose intolerance. Although lactose malabsorption was common in our study population, few subjects reported alimentary symptoms, and dietary calcium intakes were quite high. However, our oldest malabsorbers (those over 70 years of age) had both lower milk and lower calcium intakes than age-matched lactose absorbers. In old people, calcium intake and calcium absorption are often low [24] . Perhaps the mild gastrointestinal discomfort associated with the onset of reduced lactase activity may contribute to the decline in milk and dietary calcium intake, which is so widespread among elderly people [24] [25] [26] [27] .
Symptoms (bloating, diarrhoea, flatulence, pain) associated with colonic hydrogen production from lactose malabsorption can be diminished by altering nutritional habits [28] [29] [30] . We suggest that choosing dairy foods which are low in lactose (including cheeses and lactase-treated milks), consuming yoghurt rather than milk [31] [32] [33] [34] and taking milk in small regular portions rather than in large single amounts [28] may ameliorate gastrointestinal discomfort in women suffering from lactose malabsorption. This advice could help many elderly women to conserve bone by enabling malabsorbers with gastrointestinal symptoms to keep up their consumption of dairy products sufficiently to cater for their body calcium needs. Calcium supplements should be considered for those with severe intestinal symptoms and low intakes of dairy products.
Since most of our subjects maintained reasonably high calcium intakes, it is perhaps not surprising that, like Slemenda and co-workers [14] , we failed to detect any adverse effect of lactose malabsorption on current bone density. However, calcium intakes were reduced only in the oldest malabsorbers and their malabsorption was presumably of relatively recent origin. A detrimental effect of low calcium intake on bone density may therefore take some years to develop. Evaluation of even older malabsorbers could be rewarding in this regard. Men also warrant study.
We have shown that after adjusting for age, weight and dietary calcium malabsorbers did not show either lower baseline bone density values and/or faster change in bone density than absorbers. This is the first time that rate of bone change has been studied in relation to lactose absorptive status. We evaluated change in BMD for only 1 year-a longer follow-up would be useful. However, biochemical markers of bone formation and resorption were also similar in absorbers and malabsorbers, providing further support for the view that bone turnover was similar in absorbers and malabsorbers. Our findings strongly suggest that alimentary absorption of calcium is not seriously impaired in lactose malabsorbers.
Any adverse effects of lactose absorption on bone density are likely therefore to be due to reductions in calcium intake, via milk product avoidance, rather than to impaired absorption of ingested calcium. The fact that the change in bone density was modestly correlated with dietary calcium intake at two sites in the hip supports the view that low calcium intakes accelerate bone loss in elderly women. Perhaps lactose malabsorption acts as a risk factor for osteoporotic bone loss in symptomatic individuals with true lactose intolerance and very low calcium intakes [12, 13] . By contrast, lactose malabsorption unaccompanied by a reduction in dietary calcium appears to have little impact on the pathogenesis of osteoporosis. 
